2023
DOI: 10.1016/j.ajps.2023.100873
|View full text |Cite
|
Sign up to set email alerts
|

Smart stimuli-responsive drug delivery systems in spotlight of COVID-19

Zeinab Najjari,
Farzaneh Sadri,
Jaleh Varshosaz
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 210 publications
(200 reference statements)
0
1
0
Order By: Relevance
“…With an increasing focus on addressing human health needs, the demands for drug release are escalating. Controlled drug-delivery systems have become crucial in biomedicine for their ability to regulate release rate and target specific sites, thus improving drug efficacy and safety, mitigating adverse reactions, and enhancing patient compliance and comfort. Nonetheless, the selection of appropriate materials and their synthesis are critical steps in the design of drug delivery systems. , Commercially available drug carriers, including liposomes, polymer micelles, lipid nanoparticles, and hydrogels, suffer from low drug loading capacity limitation and the loss of drug activity before reaching the target tissue. Moreover, their fixed release rates hinder the achievement of personalized adjustments tailored to specific patient requirements. To overcome above-mentioned problems, metal–organic frameworks (MOFs) have emerged as a promising candidate for drug delivery due to their tunable pore size for encapsulation of particular drug molecules. Among them, adaptive MOFs exhibit great potential in achieving controlled drug release under desired conditions by selective activation under specific endogenous or exogenous stimuli.…”
Section: Introdutionmentioning
confidence: 99%
“…With an increasing focus on addressing human health needs, the demands for drug release are escalating. Controlled drug-delivery systems have become crucial in biomedicine for their ability to regulate release rate and target specific sites, thus improving drug efficacy and safety, mitigating adverse reactions, and enhancing patient compliance and comfort. Nonetheless, the selection of appropriate materials and their synthesis are critical steps in the design of drug delivery systems. , Commercially available drug carriers, including liposomes, polymer micelles, lipid nanoparticles, and hydrogels, suffer from low drug loading capacity limitation and the loss of drug activity before reaching the target tissue. Moreover, their fixed release rates hinder the achievement of personalized adjustments tailored to specific patient requirements. To overcome above-mentioned problems, metal–organic frameworks (MOFs) have emerged as a promising candidate for drug delivery due to their tunable pore size for encapsulation of particular drug molecules. Among them, adaptive MOFs exhibit great potential in achieving controlled drug release under desired conditions by selective activation under specific endogenous or exogenous stimuli.…”
Section: Introdutionmentioning
confidence: 99%